Tokyo Tape
Sign in
← Muromachi Chemicals

Half-year report · Q2

4885.TEDINET S100V2K6
Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥3.0bn2024-06-01 → 2024-11-30StandaloneNet sales
Revenue¥6.4bn2023-06-01 → 2024-05-31StandaloneNet sales (5-year summary)
Revenue¥2.9bn2023-06-01 → 2023-11-30StandaloneNet sales
Operating income¥154m2024-06-01 → 2024-11-30StandaloneOperating income
Operating income¥115m2023-06-01 → 2023-11-30StandaloneOperating income
Ordinary income¥171m2024-06-01 → 2024-11-30StandaloneOrdinary income
Ordinary income¥428m2023-06-01 → 2024-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥110m2023-06-01 → 2023-11-30StandaloneOrdinary income
Profit before tax¥171m2024-06-01 → 2024-11-30StandaloneIncome before income taxes
Profit before tax¥145m2023-06-01 → 2023-11-30StandaloneIncome before income taxes
Net income¥121m2024-06-01 → 2024-11-30StandaloneProfit loss
Net income¥330m2023-06-01 → 2024-05-31StandaloneNet income loss (5-year summary)
Net income¥93m2023-06-01 → 2023-11-30StandaloneProfit loss
Total assets¥5.5bnat 2024-11-30StandaloneAssets
Total assets¥5.1bnat 2024-05-31StandaloneAssets
Total assets¥5.1bnat 2023-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2024-11-30StandaloneLiabilities
Total liabilities¥2.8bnat 2024-05-31StandaloneLiabilities
Net assets / equity¥2.3bnat 2024-11-30StandaloneNet assets
Net assets / equity¥2.3bnat 2024-05-31StandaloneNet assets
Net assets / equity¥2.0bnat 2023-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2024-11-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-05-31StandaloneCash and deposits
Cash & equivalents¥1.3bnat 2024-11-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-05-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2023-11-30StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31dStandaloneCash and cash equivalents
Operating cash flow¥137m2024-06-01 → 2024-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥638m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥143m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥188m2024-06-01 → 2024-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥232m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥115m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥336m2024-06-01 → 2024-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥210m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥185m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥30.292024-06-01 → 2024-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.422023-06-01 → 2024-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥23.632023-06-01 → 2023-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.822024-06-01 → 2024-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥81.862023-06-01 → 2024-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥23.162023-06-01 → 2023-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥222023-06-01 → 2024-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio42.2%at 2024-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.9%at 2024-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.9%at 2023-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2024-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2024-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥1.1bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥1.1bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2024-06-01 → 2024-11-30−¥17m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥523m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥523m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥5m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥167m
—segment totalrevenue2024-06-01 → 2024-11-30¥3.0bn
—segment totalrevenue external2024-06-01 → 2024-11-30¥3.0bn
—segment totalsegment profit2024-06-01 → 2024-11-30¥154m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥55m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥28m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2023-11-30¥198m
—segment totalrevenue2023-06-01 → 2023-11-30¥2.9bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥2.9bn
—segment totalsegment profit2023-06-01 → 2023-11-30¥115m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember40043000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember213042000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember211695000JPY
Other clPrior1YearInstant_NonConsolidatedMember454671000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember250731000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember1592921000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember1620580000JPY
Long term loans payablePrior1YearInstant_NonConsolidatedMember1099300000JPY
Long term loans payableCurrentQuarterInstant_NonConsolidatedMember1442152000JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember27661000JPY
Provision for retirement benefitsCurrentQuarterInstant_NonConsolidatedMember30500000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember26227000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember53511000JPY
Long term accounts payable otherPrior1YearInstant_NonConsolidatedMember37405000JPY
Long term accounts payable otherCurrentQuarterInstant_NonConsolidatedMember30880000JPY
Other nclPrior1YearInstant_NonConsolidatedMember4531000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember3972000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember1195125000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember1561016000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember2788046000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember3181597000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember143172000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember143172000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember670161000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember677969000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember1392944000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember1426181000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-35923000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-28465000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember2170354000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember2218858000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember100866000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember103918000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember100866000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember103918000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2271221000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember2322777000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember5059267000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember5504374000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember2912325000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember2965030000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember2084058000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember2075682000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember828266000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember889347000JPY
Salaries and allowances sgaPrior1YTDDuration_NonConsolidatedMember236759000JPY
Salaries and allowances sgaCurrentYTDDuration_NonConsolidatedMember256992000JPY
Legal welfare expenses sgaPrior1YTDDuration_NonConsolidatedMember53823000JPY
Legal welfare expenses sgaCurrentYTDDuration_NonConsolidatedMember54180000JPY
Provision for bonuses sgaPrior1YTDDuration_NonConsolidatedMember55925000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-05-31pass
balance sheet identitynon_consolidated 2024-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-05-31pass
statement vs summary · net assetsnon_consolidated 2024-11-30pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · operating cash flownon_consolidated 2024-06-01/2024-11-30pass
statement vs summary · revenuenon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · revenuenon_consolidated 2024-06-01/2024-11-30pass
statement vs summary · total assetsnon_consolidated 2024-05-31pass
statement vs summary · total assetsnon_consolidated 2024-11-30pass